Related Experiment Video
Updated: May 13, 2026

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS)
Published on: March 17, 2012
Rodent models of amyotrophic lateral sclerosis
Philip McGoldrick1, Peter I Joyce, Elizabeth M C Fisher
1MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, London, WC1N 3BG, UK. p.mcgoldrick@ucl.ac.uk
None:
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterised by the degeneration of upper and lower motor neurons. Recent advances in our understanding of some of the genetic causes of ALS, such as mutations in SOD1, TARDBP, FUS and VCP have led to the generation of rodent models of the disease, as a strategy to help our understanding of the pathophysiology of ALS and to assist in the development of therapeutic strategies. This review provides detailed descriptions of TDP-43, FUS and VCP models of ALS, and summarises potential therapeutics which have been recently trialled in rodent models of the disease. This article is part of a Special Issue entitled: Animal Models of Disease.

